Experimental evidence from animal models suggests that butyrate can improve obesity-induced cognitive impairments by preventing quinolinic acid-induced BDNF reductions through inducing H3K18ac (acetylation of lysine 18 of histone H3) at BDNF promoters [91]. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.